Rigel Pharmaceuticals reported $29.85M in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Amgen AMGN:US $ 35705M 305M
Applied Genetic Technologies AGTC:US $ 11.36M 2.18M
Arrowhead Research ARWR:US $ 0 0
AstraZeneca AZN:LN 27146M 1659M
Astrazeneca AZN:US 27.15B 1.66B
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bristol Myers Squibb BMY:US $ 37107M 343M
Celldex Therapeutics CLDX:US $ 0M 0M
Chemocentryx CCXI:US $ 4M 0.55M
Daiichi Sankyo 4568:JP Y 142973M 94M
Eli Lilly And LLY:US $ 14692M 460.9M
Halozyme Therapeutics HALO:US $ 1147.13M 359.03M
IONIS PHARMACEUT IONS:US $ 1248.4M 0.47M
Karyopharm Therapeutics KPTI:US $ 302.69M 202K
Macrogenics MGNX:US $ 0 0
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Sangamo Biosciences SGMO:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Veracyte VCYT:US $ 0.6M 0M